NEW FILINGS<\/p>\n
Company: Codiak BioSciences, Inc.
\nSymbol: CDAK
\nDescription: Codiak BioSciences is harnessing exosomes\u2014natural intercellular messengers\u2014to pioneer a new class of biologic medicines, exosome therapeutics.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, William Blair, Evercore ISI
\nCo-Manager(s): WedBush PacGrow
\nFiled: 4-30-19
\nListed Cash Raise: $86.25m<\/p>\n
Company: Chewy, Inc.
\nSymbol: CHWY
\nDescription: Their mission is to be the most trusted and convenient online destination for pet parents everywhere.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Allen & Co., JP Morgan, Morgan Stanley (Alphabetical Order)
\nFiled: 4-29-19
\nListed Cash Raise: $100m<\/p>\n
Company: IDEAYA Biosciences, Inc.
\nSymbol: IDYA
\nDescription: They are an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Citigroup, Jefferies
\nFIled: 4-26-19
\nListed Cash Raise: $70m<\/p>\n
Company: Peloton Therapeutics, Inc.
\nSymbol: PLTX
\nDescription: They are a clinical stage biopharmaceutical company focused on translating novel scientific insights into first-in-class medicines for patients with cancer and other debilitating or life-threatening conditions.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Citigroup, Jefferies
\nFIled: 4-26-19
\nListed Cash Raise: $115m<\/p>\n
Company: Bicycle Therapeutics plc
\nSymbol: BCYC
\nDescription: They are a clinical-stage biopharmaceutical company developing a novel class of medicines, which we refer to as Bicycles, for diseases that are underserved by existing therapeutics.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s):Goldman Sachs, Jefferies, Piper Jaffray
\nCo-Manager(s): Canaccord Genuity
\nFiled: 4-26-19
\nListed Cash Raise: $86.25m<\/p>\n
TERMS ADDED<\/p>\n
Company: Avantor, Inc.
\nSymbol: AVTR
\nDescription: They are a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
\nShares: TBD
\nPrice Range: $18.00-$21.00
\nTrade Date: 5\/17
\nUnderwriter(s): Goldman Sachs, JP Morgan, BofA Merrill Lynch, Barclays, Jefferies
\nCo-Manager(s): Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Group, Citigroup, Piper Jaffray, RBC Capital, Cowen, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, Raymond James, Stephens Inc., Stifel, SunTrust Robinson Humphrey, Wells Fargo, Drexel Hamilton, PJT Partners
\nTerms Added: 5-3-19<\/p>\n
Company: ConversionPoint Holdings, Inc.
\nSymbol: CPTI
\nDescription: They will be a newly-combined technology company with a mission to provide a first-party data driven, end-to-end, artificial intelligence (AI)-powered e-commerce platform not previously available to small and mid-size businesses, or SMBs.
\nShares: 6.15 million
\nPrice Range: $6.00-$7.00
\nTrade Date: Tuesday, 5\/14
\nUnderwriter(s): Oppenheimer, GMP Securities
\nTerms Added: 4-30-19<\/p>\n
Company: Axcella Health Inc.
\nSymbol: AXLA
\nDescription: They are a biotechnology company pioneering the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options.
\nShares: 3.6 million
\nPrice Range: $20.00-$22.00
\nTrade Date: Thursday, 5\/9
\nUnderwriters: Goldman Sachs, JP Morgan, SVB Leerink
\nTerms Added: 4-30-19<\/p>\n
Company: Sonim Technologies, Inc.
\nSymbol: SONM
\nDescription: They are a leading U.S. provider of ultra-rugged mobile phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles.
\nShares: 3.6 million
\nPrice Range: $13.00-$15.00
\nTrade Date: Friday, 5\/10
\nUnderwriter(s): Oppenheimer, Lake Street
\nCo-Manager: National Securities
\nTerms Added: 4-30-19<\/p>\n
Company: Postal Realty Trust, Inc.
\nSymbol: PSTL
\nDescription: They are an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS.
\nShares: 5 million
\nPrice Range: $19.00-$21.00
\nTrade Date: Friday, 5\/10
\nUnderwriter(s): Stifel, Janney Montgomery Scott, BMO Capital, Height Capital Markets
\nTerms Added: 4-30-19<\/p>\n
Company: Milestone Pharmaceuticals Inc.
\nSymbol: MIST
\nDescription: They are a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
\nShares: 5 million
\nPrice Range: $14.00-$16.00
\nTrade Date: Thursday, 5\/9
\nUnderwriter(s): Jefferies, Cowen, Piper Jaffray
\nTerms Added: 4-29-19<\/p>\n
Company: South Plains Financial, Inc.
\nSymbol: SPFI
\nDescription: They are a bank holding company headquartered in Lubbock, Texas, and our wholly-owned subsidiary, City Bank, is one of the largest independent banks in West Texas.
\nShares: 3.38 million
\nPrice Range: $17.50-$19.50
\nTrade Date: Thursday, 5\/9
\nUnderwriter(s): Keefe Bruyette & Woods, Sandler O’ Neill
\nTerms Added: 4-29-19<\/p>\n
Company: Cortexyme, Inc.
\nSymbol: CRTX
\nDescription: They are a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what we believe to be a key underlying cause of Alzheimer\u2019s and other degenerative diseases.
\nShares: 4.4 million
\nPrice Range: $16.00-$18.00
\nTrade Date: Thursday, 5\/9
\nUnderwriter(s): BofA Merrill Lynch, Credit Suisse
\nCo-Manager: Canaccord Genuity, JMP Securities
\nTerms Added: 4-29-19<\/p>\n
Company: Mayville Engineering Company, Inc.
\nSymbol: MEC
\nDescription: MEC is a leading U.S.-based value-added manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly and aftermarket components.
\nShares: 6.25 million
\nPrice Range: $19.00-$21.00
\nTrade Date: Thursday, 5\/9
\nUnderwriter(s): Baird, Citigroup, Jefferies
\nCo-Manager(s): UBS Investment Bank, William Blair
\nTerms Added: 4-29-19<\/p>\n
Company: Applied Therapeutics, Inc.
\nSymbol: APLT
\nDescription: They are a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.
\nShares: 4 million
\nPrice Range: $14.00-$16.00
\nTrade Date: Thursday, 5\/9lzhe
\nUnderwriter(s): Citigroup, Cowen, UBS Investment Bank
\nCo-Manager: Baird
\nTerms Added: 4-29-19<\/p>\n
Company: NextCure, Inc.
\nSymbol: NXTC
\nDescription: They are a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function.
\nShares: 5 million
\nPrice Range: $14.00-$16.00
\nTrade Date: Thursday, 5\/9
\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Piper Jaffray
\nTerms Added: 4-29-19<\/p>\n
Company: Parsons Corporation
\nSymbol: PSN
\nDescription: They are a leading provider of technology-driven solutions in the defense, intelligence and critical infrastructure markets.
\nShares: 18.5 million
\nPrice Range: $26.00-$28.00
\nTrade Date: Wednesday, 5\/8
\nUnderwriter(s): Goldman Sachs, BofA Merrill Lynch, Morgan Stanley
\nCo-Manager(s): Jefferies, Wells Fargo, Cowen, SunTrust Robinson, MUFG, Scotiabank
\nTerms Added: 4-29-19<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-7989","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/7989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=7989"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/7989\/revisions"}],"predecessor-version":[{"id":7990,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/7989\/revisions\/7990"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=7989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=7989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=7989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}